Owner Merck Sharp & Dohme Corp.

Inventors Kim, Ronald M.; Parmee, Emma R.; Mirc, J. W.; Bittner, Amy R.; Chang, Jiang; Tan, Qiang; Sinz, Christopher Joseph

Agent Spruson & Ferguson

Pub. Number AU-A-2008296974

PCT Pub. Number WO2009/032249

Priority 60/967,827 06.09.07 US

Filing date 2 September 2008

Wipo publication date 12 March 2009

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms